While CEP7 trisomy is common in gliomas a small population of cases seen at our major reference laboratory display much higher copies numbers (≥5) of both EGFR and CEP7 that do not meet the ≥2.0 EGFR/CEP7 ratio requirement. This evidence concerns the gene EGFR and central nervous system cancer.